A patient with Schnitzler's syndrome is described presenting with fever of unknown origin. Although he had all characteristic features of the syndrome (urticarial vasculitis, hyperostosis, lymphadenopathy, fever and serum IgM monoclonal component), it was recognized very late in the diagnostic process. Cytokines were measured to get more insight into the role of cytokines in this syndrome, but only interleukin-6 was elevated. It is important for internists and rheumatologist to recognize this entity in order to prevent unnecessary diagnostic procedures. © 1997 Elsevier Science B.Y.
Introduction
Urticarial vasculitis can be secondary to many diseases causing fever of unknown origin (FUO, i.e., systemic lupus erythematosus and other connective tissue diseases, helminthic infections, hepatitis B, infectious mononucleosis, malignancies, thyroid dis eases and hypocomplementaemia with renal diseases t u .
In 1974 Schnitzler et al. [2] reported 5 patients with urticarial vasculitis together with hyperostosis,
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lymphadenopathy, fever and serum IgM monoclonal component. Even after extensive diagnostic workup no underlying cause was found and it appeared to be a specific entity. Schnitzler's syndrome has since been described in 28 cases, mostly in French [3] [4] [5] [6] [7] . Fever is an important feature of the syndrome and cases can be wrongly labeled as FUO. In computeraided literature databases like MEDLINE (Medline National Library of Medicine, Bethesda, MD) this entity cannot be found using 'fever of unknown origin' as a key word. However, it is important to recognize this syndrome as a cause of FUO, in order to prevent unnecessary diagnostic procedures.
In this case report, we present a patient with Schnitzler's syndrome, with fever as a prominent symptom leading to many unnecessary investigations in several hospitals, before recognition of the syn drome . 
Discussion
Our patient presented for a second opinion be cause of FUO. Schnitzler's syndrome was not diag nosed by many previously consulted internists. A review of the literature on Schnitzler's syndrome showed that most patients appear to share the pres ence of chronic, usually non-pruritic urticaria, recur rent fever, lymphadenopathy, monoclonal serum IgM and hyperostosis with bone pain. The prognosis is generally good, but long-term follow-up is advisable since 3 of the 28 reported cases developed a malig nancy: Waldenstrom's macroglobulinaemia, lymphoplasmocytic lymphoma and angio-immunoblastic lymphadenopathy (AILD) [6] . Our patient was exam ined in several hospitals and underwent an extensive diagnostic program, which could have been pre vented by the recognition of the syndrome. Because of the presence of monoclonal IgM it will still be necessary to perform a bone marrow biopsy in this category of patients. A possible pitfall remains the fact that AILD was found after a long follow-up in one patient with Schnitzler's syndrome. It is some times difficult to establish this diagnosis and several lymph node biopsies may be necessary.
To get more insight into the role of cytokines in the systemic features of Schnitzler's syndrome we measured cytokines in our patient. Despite the fever there were no increased circulating concentrations of known endogenous pyrogens such as TNFa and IL-1(3. IL-6 was slightly elevated in our patient, which would imply that IL-6 plays a role in some of the systemic features of the syndrome. Indeed, IL-6 is a major modulator of the acute phase reaction characterized by fever, leukocytosis, increased vas cular permeability and elevation of acute phase pro tein [9] .
To date, the pathophysiological mechanism of this syndrome has not yet been clarified. IgM and IgG antibodies against interleukin-lot (IL -la) have been shown in serum and human epidermis [10] , which would imply a pathophysiological role for IL-1 in the systemic features of this syndrome. However, the physiological role of circulating auto-antibodies is not clear at all, because auto-antibodies (mostly of the IgG but sometimes also IgM) are detectable in 24% of apparently normal adults [11] .
No specific therapy for patients with Schnitzler's syndrome is available. Systemic corticosteroids are first choice in therapy, NSAID's are also used suc cessfully [4] , Colchicine also appeal's to be effective [12] and often, as in our patient, a combination is necessary to suppress symptoms.
